News

PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery

April 6, 2023・Businesswire PARAMUS, N.J.–(BUSINESS WIRE)–PsychoGenics Inc. (“PsychoGenics” or the “Company”), a leader in AI-enabled phenotypic drug discovery and preclinical CRO...

News

PsychoGenics Highlights a Long-term Collaboration with the TSC Alliance on Rare Disease Day

Feb. 28, 2023 On this Rare Disease Day, we want to highlight and honor our long-term collaboration with the TSC...

News

PsychoGenics CEO Explores CNS Drug Development Trends

February 4, 2023 · By Brian Buntz · Drug Discovery & Development In the late 2000s, many companies, particularly Big...

Partner with us and transform your program

DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS

Get Started